An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

NCT05369832 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

139

Enrollment

INDUSTRY

Sponsor class

Stopped Business objectives have changed.

Conditions

Colitis, Ulcerative

Interventions

DRUG: Ozanimod

Sponsor

Bristol-Myers Squibb